Evidence map›Paper›PMID 26910181›Full record

ArticleThe American journal of drug and alcohol abuse2016

Comparison of outcome expectancies for synthetic cannabinoids and botanical marijuana.

Kirstin J Lauritsen, Harold Rosenberg

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in The American journal of drug and alcohol abuse, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 29 citations in OpenAlex.

  1. Characterization of the Antitumor Potential of Extracts ofInternational journal of molecular sciences · 2023
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Cannabinoids for SARS-CoV-2 and is there evidence of their therapeutic efficacy?Turkish journal of biology = Turk biyoloji dergisi · 2021
    Article
  7. Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases.International journal of molecular sciences · 2020
    Review
  8. Article
  9. Article
  10. Synthetic cannabinoids: undesirable alternatives to natural marijuana.The American journal of drug and alcohol abuse · 2016
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kirstin J Lauritsena Department of Psychology , Bowling Green State University , Bowling Green , OH , USA.
Harold Rosenberga Department of Psychology , Bowling Green State University , Bowling Green , OH , USA.
Bowling Green State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough initially developed for medical purposes, synthetic cannabinoids have also been consumed for recreational purposes.

objectiveTo evaluate whether agreement with positive and negative outcome expectancies differed for synthetic cannabinoids versus botanical marijuana, and assess reported reasons for using synthetic cannabinoids.

methodUsing a web-based recruitment and data collection procedure, 186 adults who had used both synthetic cannabinoids and botanical marijuana and 181 adults who had used botanical marijuana but not synthetic cannabinoids, completed measures of outcome expectancies and other relevant questionnaires.

resultsA significant interaction revealed that participants who had used both synthetic cannabinoids and botanical marijuana indicated lower agreement with positive expectancies for synthetic cannabinoids, and higher agreement with positive expectancies for botanical marijuana, than did those participants who used only botanical marijuana. There was no interaction between type of drug and use history on agreement with negative expectancies, and participants agreed more strongly with negative outcome expectancies for synthetic cannabinoids than for botanical marijuana whether they had used one or both types of these drugs. The most frequently provided reasons for using synthetic cannabinoids included availability, perceived legality, cost, curiosity, and social interaction.

conclusionGiven growing public acceptance of recreational and medical marijuana, coupled with negative perceptions and increasing regulation of synthetic cannabinoid compounds, botanical marijuana is likely to remain more available and more popular than synthetic cannabinoids.

Indexed as

Health Knowledge, Attitudes, PracticeAdultCannabinoidsDrug UsersFemaleHumansMaleMarijuana SmokingYoung AdultCannabinoidsmarijuanaoutcome expectanciesSynthetic cannabinoids

Identifiers

PMID26910181
OpenAlexW2291109469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.